Pen-sharing poses a risk for transmission of blood-borne pathogens Adverse Reactions Most common adverse reactions (incidence 5%) are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with T2D, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss Drug Interactions When initiating Wegovy , consider reducing the dose of concomitantly administered insulin secretagogues or insulin to reduce the risk of hypoglycemia
The most common storage errors patients make are small but devastating: Leaving the vial unrefrigerated for an hour Storing it in a fridge that fluctuates in temperature Allowing it to sit in a warm car or delivery box Not realizing their freezer had partially frozen the vial Traveling with it improperly Allowing light exposure Shaking the vial instead of gently inverting it Each of these damages peptide integrity, and you have no way of visually confirming it
With this device, we track our patients weight, percent body fat, muscle mass, metabolism, hydration status, visceral fat, and more
Conclusions We demonstrated that TIR can ameliorate high glucose-induced neurodegeneration and overcome neuronal insulin resistance
Tirzepatide users often describe a whoosh of weight loss after each dose increase, one to two pounds a week isnt uncommon
Understanding your specific syringe matters as much as understanding your vial concentration
